Peter A Ward

US Patent:

7168208, Jan 30, 2007

Filed:

Apr 12, 2002

Appl. No.:

10/121178

Inventors:

Peter Francis Ward - Brookline MA, US

International Classification:

B60R 27/00

US Classification:

49462, 296207, 206453

Abstract:

This invention relates to a safety guard designed and adapted for use on the corners of vehicle doors to protect passengers from accidental contact with the sharp corner of a vehicle door. The door guard is particularly well suited to cars with a “bubble-wrap” design, which results in the tops of the vehicle doors having sharp corners that may be less than ninety degrees. At least two plates, preferably triangular in shape and made of plastic or some other suitable material, are joined together on at least one side thereof and installed on a vehicle door to cover potentially hazardous sharp metallic corners of the vehicle door. The door guard may be affixed to the door using glue, or the plates of the door guard may have pre-drilled openings for screws to attach the door guard to the door. Variations in the thickness and shape of the plates may be necessary to conform to different vehicle types without interfering with the operation of the door. The door guard of the present invention may also be adapted for use on the trunk cover or hood cover of a vehicle.

US Patent:

20040014031, Jan 22, 2004

Filed:

Aug 7, 2002

Appl. No.:

10/212772

Inventors:

Anna Salvetti - Nantes, FR
Gilliane Chadeuf - Nantes, FR
Jacques Tessier - Nantes, FR
Philippe Moullier - Basse-Goulaine, FR
Michael Linden - New York NY, US
Peter Ward - New York NY, US
Alberto Epstein - Lyon, FR

International Classification:

C12Q001/70
C12P019/34
C12N015/85

US Classification:

435/005000, 435/455000, 435/091100

Abstract:

The present invention relates to an isolated nucleic acid sequence comprising a first DNA sequence comprising a cis-acting replication element (CARE) from an Adeno-Associated Virus (AAV), and a second DNA sequence operably linked to said CARE, wherein amplification of said isolated nucleic acid sequence occurs when said isolated nucleic acid sequence is integrated in the genome of a cell and said cell is contacted with a CARE-dependent replication unducer (CARE-DRI). It also relates to amplification methods using a CARE-dependent replication inducer (CARE-DRI) and packaging cell-lines wherein replication of the integrated rep and cap genes is inducible by a CARE-DRI.